Cargando…
Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
OBJECTIVE: To investigate the infection status of high-risk human papillomavirus (HR-HPV) E6/E7 mRNA in patients with a cytological diagnosis of “atypical squamous cells of undetermined significance” (ASCUS) and to analyze the pathogenic rate of different high-risk HPV subtypes combined with biopsy...
Autores principales: | Jin, Xiu, Liu, Feifei, Zhang, Ya, Ma, Yingying, Yang, Linqing, Wang, Yunfei, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503067/ https://www.ncbi.nlm.nih.gov/pubmed/37710244 http://dx.doi.org/10.1186/s12905-023-02599-3 |
Ejemplares similares
-
Prognostic and diagnostic validity of p16/Ki-67, HPV E6/E7 mRNA, and HPV DNA in women with ASCUS: a follow-up study
por: Ren, Chenchen, et al.
Publicado: (2019) -
Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
por: Liu, Ying, et al.
Publicado: (2023) -
Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS
por: Zhu, Yuanhang, et al.
Publicado: (2019) -
Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: Cao, Limei, et al.
Publicado: (2022) -
Retracted: Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)